Clinical Trial Update: Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal Neuralgia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SR750 for trigeminal neuralgia reported on efficacy, safety, and tolerability, and the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trigeminal Neuralgia

Drugs mentioned

• SR750

Snippet

Sponsor: Shanghai SIMR Biotechnology Co., Ltd. | Conditions: Trigeminal Neuralgia | Phase 2 | Status: COMPLETED